SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ricardo U. Macías-Rodríguez, Andrés Duarte-Rojo, Carlos Cantú-Brito, Tilman Sauerbruch, Astrid Ruiz-Margáin, Jonel Trebicka, Marina Green-Gómez, Jorge B. Díaz Ramírez, Manuel Sierra Beltrán, Misael Uribe-Esquivel, Aldo Torre, Cerebral haemodynamics in cirrhotic patients with hepatic encephalopathy, Liver International, 2015, 35, 2
  2. 2
    Abolhassan Shakeri, Mojtaba Varshochi, Naser Atapour, Masoud Nemati, Manoochehr Khoshbaten, Daniel Fadaei Fouladi, Vascular Doppler ultrasonographic indices in cirrhosis: a case–control study with emphasis on the common carotid arteries, La radiologia medica, 2015,

    CrossRef

  3. 3
    Anna Licata, Alessandra Mazzola, Daniela Ingrassia, Vincenza Calvaruso, Calogero Cammà, Antonio Craxì, Clinical implications of the hyperdynamic syndrome in cirrhosis, European Journal of Internal Medicine, 2014, 25, 9, 795

    CrossRef

  4. 4
    Vicente Arroyo, Rita García-Martinez, Xavier Salvatella, Human serum albumin, systemic inflammation, and cirrhosis, Journal of Hepatology, 2014, 61, 2, 396

    CrossRef

  5. 5
    J. A. Leithead, P. C. Hayes, J. W. Ferguson, Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction, Alimentary Pharmacology & Therapeutics, 2014, 39, 7
  6. 6
    Justin M. Belcher, Chirag R. Parikh, Guadalupe Garcia–Tsao, Acute Kidney Injury in Patients With Cirrhosis: Perils and Promise, Clinical Gastroenterology and Hepatology, 2013, 11, 12, 1550

    CrossRef

  7. 7
    Jasmohan S. Bajaj, Vishwadeep Ahluwalia, James B. Wade, Arun J. Sanyal, Melanie B. White, Nicole A. Noble, Pamela Monteith, Michael Fuchs, Richard K. Sterling, Velimir Luketic, Iliana Bouneva, Richard T. Stravitz, Puneet Puri, Kenneth A. Kraft, HoChong Gilles, Douglas M. Heuman, Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis, Journal of Hepatology, 2013, 58, 1, 38

    CrossRef

  8. 8
    André Nazar, Mónica Guevara, Marta Sitges, Carlos Terra, Elsa Solà, Carina Guigou, Vicente Arroyo, Pere Ginès, LEFT ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunction, Journal of Hepatology, 2013, 58, 1, 51

    CrossRef

  9. You have free access to this content9
    Vicente Arroyo, Javier Fernández, Relationship between systemic hemodynamics, renal dysfunction, and fluid retention in cirrhosis, Clinical Liver Disease, 2013, 2, 3
  10. 10
    Vicente Arroyo, Javier Fernández, Bases fisiopatológicas del uso de la albúmina humana en la cirrosis hepática, Gastroenterología y Hepatología, 2012, 35, 1, 42

    CrossRef

  11. 11
    Cláudia Fagundes, Pere Ginès, Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis, American Journal of Kidney Diseases, 2012, 59, 6, 874

    CrossRef

  12. 12
    R. Jalan, S.W.M. Olde Damink, J.C. ter Steege, D.N. Redhead, A. Lee, P.C. Hayes, N.E.P. Deutz, Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients, Journal of Hepatology, 2011, 54, 2, 265

    CrossRef

  13. 13
    James Y. Findlay, Oren K. Fix, Catherine Paugam-Burtz, Linda Liu, Puneet Sood, Stephen J. Tomlanovich, Jean Emond, Critical care of the end-stage liver disease patient awaiting liver transplantation, Liver Transplantation, 2011, 17, 5
  14. 14
    Evangelos Kalaitzakis, Is fatigue related to suppression of hypothalamic–pituitary–adrenal axis activity by bile acids in chronic liver disease?, Medical Hypotheses, 2011, 77, 3, 464

    CrossRef

  15. 15
    Yeon Seok Seo, Vijay H Shah, Pathophysiology of Portal Hypertension and Its Clinical Links, Journal of Clinical and Experimental Hepatology, 2011, 1, 2, 87

    CrossRef

  16. 16
    George Kalambokis, Epameinondas V. Tsianos, Pitfalls in the assessment of intrapulmonary shunt using lung perfusion scintigraphy in patients with cirrhosis, Liver International, 2011, 31, 1
  17. 17
    A. Canbay, O. Witzke, G. Gerken, Hepatorenales Syndrom, Intensivmedizin und Notfallmedizin, 2010, 47, 8, 565

    CrossRef

  18. 18
    George Kalambokis, Epameinondas V. Tsianos, Lung perfusion scan is not superior to contrast-enhanced echocardiography for the diagnosis of the hepatopulmonary syndrome in chronic liver disease, European Journal of Gastroenterology & Hepatology, 2010, 22, 11, 1387

    CrossRef

  19. 19
    B. Javier Brahm, P. Rodrigo Quera, Síndrome hepatorenal: patogénesis y tratamiento, Revista Médica Clínica Las Condes, 2010, 21, 4, 613

    CrossRef

  20. 20
    T. Gustot, F. Durand, D. Lebrec, R. Moreau, Réanimation hépatosplanchnique, 2010,

    CrossRef

  21. 21
    Giorgio La Villa, Paolo Gentilini, Hemodynamic alterations in liver cirrhosis, Molecular Aspects of Medicine, 2008, 29, 1-2, 112

    CrossRef

  22. 22
    Isabelle Colle, Anja M. Geerts, Christophe Van Steenkiste, Hans Van Vlierberghe, Hemodynamic Changes in Splanchnic Blood Vessels in Portal Hypertension, The Anatomical Record, 2008, 291, 6
  23. 23
    Rosa Novellas, Rafael Ruiz de Gopegui, Yvonne Espada, Increased renal vascular resistance in dogs with hepatic disease, The Veterinary Journal, 2008, 178, 2, 257

    CrossRef

  24. 24
    Javier Fernández, Mercedes Fernández-Balsells, Juan Acevedo, Vicente Arroyo, Insuficiencia suprarrenal relativa en la insuficiencia hepática aguda y crónica, Gastroenterología y Hepatología, 2008, 31, 9, 606

    CrossRef

  25. 25
    P. Gentilini, G. La Villa, Liver–kidney pathophysiological interrelationships in liver diseases, Digestive and Liver Disease, 2008, 40, 12, 909

    CrossRef

  26. 26
    Vicente Arroyo, Javier Fernandez, Antoni Mas, Angels Escorsell, Molecular adsorbents recirculating system (MARS) and the failing liver: A negative editorial for a positive trial?, Hepatology, 2008, 47, 6
  27. 27
    Paolo Angeli, Carlo Merkel, Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis, Journal of Hepatology, 2008, 48, S93

    CrossRef

  28. 28
    Arun J. Sanyal, Jaime Bosch, Andres Blei, Vincente Arroyo, Portal Hypertension and Its Complications, Gastroenterology, 2008, 134, 6, 1715

    CrossRef

  29. 29
    Angelo Gatta, Massimo Bolognesi, Carlo Merkel, Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis, Molecular Aspects of Medicine, 2008, 29, 1-2, 119

    CrossRef

  30. 30
    Vicente Arroyo, Carlos Terra, Pere Ginès, Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome, Journal of Hepatology, 2007, 46, 5, 935

    CrossRef

  31. 31
    Gavin Wright, Rajiv Jalan, Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box?, Hepatology, 2007, 46, 2
  32. 32
    Gavin Wright, Nathan A. Davies, Debbie L. Shawcross, Stephen J. Hodges, Claudia Zwingmann, Heather F. Brooks, Ali R. Mani, David Harry, Vanessa Stadlbauer, Zheng Zou, Roger Williams, Ceri Davies, Kevin P. Moore, Rajiv Jalan, Endotoxemia produces coma and brain swelling in bile duct ligated rats, Hepatology, 2007, 45, 6
  33. 33
    Charmaine A Stewart, Glenn E Smith, Minimal hepatic encephalopathy, Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4, 12, 677

    CrossRef

  34. 34
    Mónica Guevara, Juan Rodés, Síndrome hepatorrenal, Diálisis y Trasplante, 2007, 28, 4, 150

    CrossRef

  35. 35
    María E. Baccaro, Mónica Guevara, Síndrome hepatorrenal, Gastroenterología y Hepatología, 2007, 30, 9, 548

    CrossRef

  36. 36
    Ming-Hung Tsai, Splanchnic and Systemic Vasodilatation, Journal of Clinical Gastroenterology, 2007, 41, Supplement 3, S266

    CrossRef

  37. 37
    Andrés Cárdenas, Pere Gin_s, Sodium in Health and Disease, 2007,

    CrossRef

  38. 38
    Javier Fernández, Angels Escorsell, Michel Zabalza, Vanessa Felipe, Miguel Navasa, Antoni Mas, Antonio M. Lacy, Pere Ginès, Vicente Arroyo, Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival, Hepatology, 2006, 44, 5
  39. 39
    William T. Merritt, Perioperative Concerns in Acute Liver Failure, International Anesthesiology Clinics, 2006, 44, 4, 37

    CrossRef

  40. 40
    Yasuko Iwakiri, Roberto J. Groszmann, The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule, Hepatology, 2006, 43, S1
  41. 41
    Luis Ruiz-del-Arbol, Alberto Monescillo, Carlos Arocena, Paz Valer, Pere Ginès, Víctor Moreira, José María Milicua, Wladimiro Jiménez, Vicente Arroyo, Circulatory function and hepatorenal syndrome in cirrhosis, Hepatology, 2005, 42, 2
  42. 42
    A.T. Blei, MARS y el tratamiento de la encefalopatía hepática, Gastroenterología y Hepatología, 2005, 28, 2, 100

    CrossRef

  43. 43
    Andres T. Blei, Monitoring cerebral blood flow: A useful clinical tool in acute liver failure?, Liver Transplantation, 2005, 11, 11
  44. 44
    Paolo Sorrentino, Giovanni Tarantino, Paolo Conca, Paola Ragucci, Alessandro Perrella, Abnormally high resistive index of central retinal artery by ultrasound color Doppler in patients with viral chronic liver disease: correlation with worsening liver staging, Ultrasound in Medicine & Biology, 2004, 30, 5, 599

    CrossRef

  45. 45
    ANDRES T BLEI, Albumin dialysis for the treatment of hepatic encephalopathy, Journal of Gastroenterology and Hepatology, 2004, 19,
  46. 46
    Luisa Spadaro, Massimo Bolognesi, Alessandra Pierobon, Giancarlo Bombonato, Angelo Gatta, David Sacerdoti, Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: relationships with splanchnic haemodynamics, Ultrasound in Medicine & Biology, 2004, 30, 1, 19

    CrossRef

  47. 47
    Andres T Blei, Infection, inflammation and hepatic encephalopathy, synergism redefined, Journal of Hepatology, 2004, 40, 2, 327

    CrossRef

  48. 48
    P. Ginès, A. Torre, C. Terra, M. Guevara, Pharmacological treatment of hepatorenal syndrome, Alimentary Pharmacology & Therapeutics, 2004, 20,
  49. 49
    Luis Ruiz Del Árbol, Vicente Arroyo, Reply:, Hepatology, 2004, 39, 3
  50. 50
    Vicente Arroyo, Jordi Colmenero, Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management, Journal of Hepatology, 2003, 38, 69

    CrossRef

  51. 51
    A. Cárdenas, A. Sánchez-Fueyo, Disfunción circulatoria en la cirrosis. Fisiopatología y consecuencias clínicas, Gastroenterología y Hepatología, 2003, 26, 7, 447

    CrossRef

  52. 52
    Pere Ginès, Mónica Guevara, Vicente Arroyo, Juan Rodés, Hepatorenal syndrome, The Lancet, 2003, 362, 9398, 1819

    CrossRef

  53. 53
    Motoh Iwasa, Kaname Matsumura, Yuri Watanabe, Mika Yamamoto, Masahiko Kaito, Jiro Ikoma, Esteban C. Gabazza, Kan Takeda, Yukihiko Adachi, Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis, European Journal of Gastroenterology & Hepatology, 2003, 15, 7, 733

    CrossRef

  54. 54
    Motoh Iwasa, Kaname Matsumura, Yuri Watanabe, Mika Yamamoto, Masahiko Kaito, Jiro Ikoma, Esteban C Gabazza, Kan Takeda, Yukihiko Adachi, Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis, European Journal of Gastroenterology & Hepatology, 2003, 15, 7, 733

    CrossRef

  55. 55
    Andrés Cárdenas, Vicente Arroyo, Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites, Best Practice & Research Clinical Endocrinology & Metabolism, 2003, 17, 4, 607

    CrossRef

  56. 56
    D Aguillon, P Seguin, Y Mallédant, Syndrome hépatorénal : de la physiopathologie au traitement, Annales Françaises d'Anesthésie et de Réanimation, 2003, 22, 1, 30

    CrossRef

  57. 57
    Chuhan Chung, Javier Vaquero, Jeanne Gottstein, Andres T Blei, Vasopressin accelerates experimental ammonia-induced brain edema in rats after portacaval anastomosis, Journal of Hepatology, 2003, 39, 2, 193

    CrossRef

  58. 58
    Vicente Arroyo, Mónica Guevara, Pere Ginès, Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment, Gastroenterology, 2002, 122, 6, 1658

    CrossRef

  59. 59
    V Arroyo, Review article: albumin in the treatment of liver diseases—new features of a classical treatment, Alimentary Pharmacology & Therapeutics, 2002, 16,
  60. 60
    G. La Villa, G. Barletta, D. Righi, M. Foschi, R. Del Bene, R. Tarquini, P. Pantaleo, P. Gentilini, G. Laffi, Vascular reserve in the lower limbs of cirrhotic patients: a duplex Doppler ultrasound study, Digestive and Liver Disease, 2002, 34, 10, 717

    CrossRef

  61. 61
    Manri Kawakami, Masahiko Koda, Yoshikazu Murawaki, Hironaka Kawasaki, Shiro Ikawa, Cerebral vascular resistance assessed by transcranial color Doppler ultrasonography in patients with chronic liver diseases, Journal of Gastroenterology and Hepatology, 2001, 16, 8
  62. 62
    Masatoshi Kudo, Cerebral vascular resistance in hepatic insufficiency, Journal of Gastroenterology and Hepatology, 2001, 16, 8
  63. 63
    Shigeo Sugano, Kunihiro Yamamoto, Toshihiko Atobe, Manabu Watanabe, Noritaka Wakui, Naoya Iwasaki, Miwako Toyota, Postprandial middle cerebral arterial vasoconstriction in cirrhotic patients. A placebo, controlled evaluation, Journal of Hepatology, 2001, 34, 3, 373

    CrossRef

  64. 64
    K.V. Narayanan Menon, Patrick S. Kamath, REGIONAL AND SYSTEMIC HEMODYNAMIC DISTURBANCES IN CIRRHOSIS, Clinics in Liver Disease, 2001, 5, 3, 617

    CrossRef

  65. 65
    Laurence Blendis, Florence Wong, The hyperdynamic circulation in cirrhosis, Pharmacology & Therapeutics, 2001, 89, 3, 221

    CrossRef

  66. 66
    Pere Ginès, Diagnosis and treatment of hepatorenal syndrome, Best Practice & Research Clinical Gastroenterology, 2000, 14, 6, 945

    CrossRef

  67. 67
    Ramón Bataller, Pere Ginès, Vicente Arroyo, Juan Rodés, HEPATORENAL SYNDROME, Clinics in Liver Disease, 2000, 4, 2, 487

    CrossRef

  68. 68
    Andrés Cárdenas, Ramón Bataller, Vicente Arroyo, MECHANISMS OF ASCITES FORMATION, Clinics in Liver Disease, 2000, 4, 2, 447

    CrossRef

  69. 69
    Juan Uriz, Andrés Cárdenas, Vicente Arroyo, Pathophysiology, diagnosis and treatment of ascites in cirrhosis, Best Practice & Research Clinical Gastroenterology, 2000, 14, 6, 927

    CrossRef

  70. 70
    Francesc Cardellach, Pere Ginès Rolando Ortega, Rolando Ortega, Juan Uriz, Síndrome hepatorrenal: nuevos aspectos fisiopatológicos y terapéuticos, Medicina Clínica, 2000, 115, 14, 549

    CrossRef

  71. 71
    M. Bernardi, L. Blendis, A. K. Burroughs, G. Laffi, J. Rodes, P. Gentilini, Hepatorenal syndrome and ascites - questions and answers, Liver, 1999, 19,
  72. 72
    Andres T Blei, Fin Stolze Larsen, Pathophysiology of cerebral edema in fulminant hepatic failure, Journal of Hepatology, 1999, 31, 4, 771

    CrossRef